{"url_path":"/sec/cik-0000786947/8-k/2026-06-29/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/786947/0001104659-26-078839-index.html","accession_number":"0001104659-26-078839","cik":"0000786947","ticker":null,"issuer_name":"ACURA PHARMACEUTICALS, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/786947/0001104659-26-078839-index.html","primary_entity_key":"0000786947","primary_entity_name":"ACURA PHARMACEUTICALS, INC"},"word_count":165,"has_tables":true,"body_markdown":"**Item 9.01 - Financial Statements and Exhibits**\n\n \n\n**Exhibit Number**\n**Description**\n\n[99.1](tm2619325d1_ex99-1.htm)\n[Amended Loan Schedule dated June 29, 2026 to the November 10, 2022 Amended, Consolidated and Restated Secured Promissory Note with Abuse Deterrent Pharma, LLC](tm2619325d1_ex99-1.htm)\n\n[99.2](tm2619325d1_ex99-2.htm)\n[Amendment #14 dated June 15, 2026 to the License, Development and Commercialization Agreement with Abuse Deterrent Pharma, LLC](tm2619325d1_ex99-2.htm)\n\n[99.3](tm2619325d1_ex99-3.htm)\n[Amendment #8 dated June 15, 2026 to the November 10, 2022 Amended, Consolidated and Restated Secured Promissory Note with Abuse Deterrent Pharma, LLC](tm2619325d1_ex99-3.htm)\n\n[99.4](tm2619325d1_ex99-4.htm)\n[Amendment #6 dated June 15, 2026 to the  June 28, 2019 Common Stock Purchase Warrant with Abuse Deterrent Pharma, LLC](tm2619325d1_ex99-4.htm)\n\n104\nCover Page Interactive Data File (embedded within Inline XBRL document)\n\n \n\n \n\n4\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n**ACURA PHARMACEUTICALS, INC.**\n\n \n \n\n \nBy:\n/s/ Robert A. Seiser\n\n \n \nRobert A. Seiser\n\n \n \nSenior Vice President & Chief Financial Officer\n\n \n\nDate:     June 29, 2026\n\n \n\n5"}